These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 5510364)
21. Myocardial reactive hyperemia responses in the dog after aminophylline and lidoflazine. Bittar N; Pauly TJ Am J Physiol; 1971 Mar; 220(3):812-5. PubMed ID: 4322835 [No Abstract] [Full Text] [Related]
22. [Effects of flavon-7-ethyl oxyacetate on the cardiovascular system]. Takenaka F; Takeya N; Tazume Y; Hayakawa T; Sakai M Kumamoto Igakkai Zasshi; 1967 Sep; 41(9):843-8. PubMed ID: 5631463 [No Abstract] [Full Text] [Related]
23. [Various aspects of the pharmacology of iproveratril, a new synthetic coronary dilator with anti-arrhythmic value]. Melville KI; Shister HE; Mignault Jde L; Garvey L Union Med Can; 1969 Apr; 98(4):592-6. PubMed ID: 5355792 [No Abstract] [Full Text] [Related]
24. Enhancement of coronary vasodilating action of ATP and adenosine by lidoflazine. Afonso S; O'Brien GS; Crumpton CW Circ Res; 1968 Jan; 22(1):43-8. PubMed ID: 5635208 [No Abstract] [Full Text] [Related]
25. Some effects of iproveratril (Isoptin) on the cardiovascular system. Nayler WG; McInnes I; Swann JB; Price JM; Carson V; Race D; Lowe TE J Pharmacol Exp Ther; 1968 Jun; 161(2):247-61. PubMed ID: 5650138 [No Abstract] [Full Text] [Related]
26. Inhibitory effect of lidoflazine on contractions of isolated canine coronary arteries caused by norepinephrine, 5-hydroxytryptamine, high potassium, anoxia and ergonovine maleate. Van Neuten JM; Van Beek J; Vanhoutte PM J Pharmacol Exp Ther; 1980 Apr; 213(1):179-87. PubMed ID: 7359366 [TBL] [Abstract][Full Text] [Related]
27. The subcellular distribution of calcium and the effects of calcium-antagonists as evaluated with a combined oxalate-pyroantimonate technique. Borgers M; Thoné F; van Nueten JM Acta Histochem Suppl; 1981; 24():327-32. PubMed ID: 6165047 [No Abstract] [Full Text] [Related]
28. Regional blood flow and cardiac responses to hydralazine. Spokas EG; Wang HH J Pharmacol Exp Ther; 1980 Feb; 212(2):294-303. PubMed ID: 7351643 [No Abstract] [Full Text] [Related]
29. [Evaluation of the effect of a coronary vasodilator]. Nakamura Y; Nagoshi H; Takei F; Takahashi M; Matsumura N Kokyu To Junkan; 1972 Sep; 20(9):805-9. PubMed ID: 4676839 [No Abstract] [Full Text] [Related]
30. [Experimental coronary-dilatator action of derivatives of phenyl-propyl-di-indolylpropylamine and phenyl-propyl-diphenylpropylamine]. Mercier F; Gavend MR; Gavend M Therapie; 1966; 21(3):599-614. PubMed ID: 5942126 [No Abstract] [Full Text] [Related]
31. Augmentation of coronary collaterals and protection against the consequences of coronary ligation following the administration of dipyridamole. Schmier J; Kaden F; Schmidt HD Brux Med; 1970 Sep; 50(9):617-22. PubMed ID: 5510362 [No Abstract] [Full Text] [Related]
32. [Serotoninergic 1A receptors (5-HT1A) and the regulation of blood pressure]. Dabire H Therapie; 1990; 45 Suppl 2():183-6. PubMed ID: 2339340 [No Abstract] [Full Text] [Related]
33. The disappearance of adenosine in blood. Effect of lidoflazine and other drugs. Van Belle H Eur J Pharmacol; 1970 Jul; 11(2):241-8. PubMed ID: 5447806 [No Abstract] [Full Text] [Related]
34. [Selective influencing of the myocardial blood supply in dogs using drugs]. Hapke HJ Dtsch Tierarztl Wochenschr (1946); 1969 Oct; 76(19):518-21. PubMed ID: 5355903 [No Abstract] [Full Text] [Related]
35. [Phenylbutylamino derivatives with a stimulating effect on the adrenergic beta-receptors and their action on the coronary circulation of dogs]. Becker KH; Boltze KH; Lorenz D; Oberdörster G Arzneimittelforschung; 1966 Jul; 16(7):833-5. PubMed ID: 6014711 [No Abstract] [Full Text] [Related]
36. [Piperazine-derivatives. II. Effect of piperazine-derivatives]. Lányi K; Erdélyi I; Institoris E; Tardos L; Szabó Z Arzneimittelforschung; 1968 Nov; 18(11):1431-5. PubMed ID: 5755908 [No Abstract] [Full Text] [Related]
38. [Chromotropic, inotropic and coronary dilator actions of some heptaminol derivatives]. Duchêne-Marullaz P; Cosnier D; Szabo S; Mollat F Therapie; 1968; 23(2):383-97. PubMed ID: 5701513 [No Abstract] [Full Text] [Related]
39. [Cardiovascular protection by estrogens: a calcium antagonist effect?]. Sánchez García P An R Acad Nac Med (Madr); 1994; 111(4):779-82. PubMed ID: 7598211 [No Abstract] [Full Text] [Related]